- Home
- OCS vs AC Comparison
OCS vs AC Comparison
Compare OCS & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- AC
- Stock Information
- Founded
- OCS 2003
- AC 1976
- Country
- OCS Switzerland
- AC United States
- Employees
- OCS N/A
- AC N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- AC Investment Bankers/Brokers/Service
- Sector
- OCS Health Care
- AC Finance
- Exchange
- OCS Nasdaq
- AC Nasdaq
- Market Cap
- OCS 904.3M
- AC 809.6M
- IPO Year
- OCS N/A
- AC N/A
- Fundamental
- Price
- OCS $19.03
- AC $38.68
- Analyst Decision
- OCS Strong Buy
- AC
- Analyst Count
- OCS 4
- AC 0
- Target Price
- OCS $29.50
- AC N/A
- AVG Volume (30 Days)
- OCS 42.6K
- AC 5.2K
- Earning Date
- OCS 03-11-2025
- AC 05-08-2025
- Dividend Yield
- OCS N/A
- AC 5.70%
- EPS Growth
- OCS N/A
- AC 20.73
- EPS
- OCS N/A
- AC 2.08
- Revenue
- OCS $757,024.00
- AC $13,175,000.00
- Revenue This Year
- OCS $927.26
- AC N/A
- Revenue Next Year
- OCS $292.79
- AC N/A
- P/E Ratio
- OCS N/A
- AC $18.45
- Revenue Growth
- OCS N/A
- AC 3.88
- 52 Week Low
- OCS $10.55
- AC $28.58
- 52 Week High
- OCS $23.08
- AC $43.85
- Technical
- Relative Strength Index (RSI)
- OCS 42.80
- AC 67.06
- Support Level
- OCS $18.30
- AC $35.30
- Resistance Level
- OCS $20.00
- AC $39.20
- Average True Range (ATR)
- OCS 0.71
- AC 0.88
- MACD
- OCS 0.09
- AC 0.37
- Stochastic Oscillator
- OCS 61.35
- AC 87.96
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.